CFR Presents

Asia Unbound

CFR experts give their take on the cutting-edge issues emerging in Asia today.

Posts by Author

Showing posts for "Yanzhong Huang"

The Rising Anti-Intellectualism in China: Part I

by Yanzhong Huang
Graduates, in academic dress, pose for pictures in front of a statue of late Chinese leader Mao Zedong at a university in Shanghai, June 19, 2015. (Reuters/Aly Song) Graduates, in academic dress, pose for pictures in front of a statue of late Chinese leader Mao Zedong at a university in Shanghai, June 19, 2015. (Reuters/Aly Song)

On June 10, a blogger named Zhou Xiaoping was elected to head the newly established China Online Writers Association in Sichuan Province. He thus followed the career path of another popular blogger, Hua Qianfang, who was elected the Vice Chairman of the Writers Association of Fushun City in Liaoning Province in November 2014, an honor that is usually reserved for professional writers whose achievements in literature are well recognized. While both of them received only secondary school education, Zhou and Hua were invited to join the seventy most famous writers and artists in attending a symposium on art and literature in Beijing last year.  Read more »

Does MERS Pose a Serious Threat to China?

by Yanzhong Huang
A health worker with protective suits sitting with people who came into close contact with the Korean MERS patient arrive at Lady MacLehose Holiday Village in Sai Kung, where they will spend two weeks in quarantine, in Hong Kong, China May 30, 2015. China said on Friday a 44-year-old South Korean man had tested positive for Middle East Respiratory Syndrome (MERS), China's first confirmed case, but that it had not found any symptoms in 38 people who had been in close contact with him. (Reuters/Tyrone Siu) A health worker with protective suits sitting with people who came into close contact with the Korean MERS patient arrive at Lady MacLehose Holiday Village in Sai Kung, where they will spend two weeks in quarantine, in Hong Kong, China May 30, 2015. China said on Friday a 44-year-old South Korean man had tested positive for Middle East Respiratory Syndrome (MERS), China's first confirmed case, but that it had not found any symptoms in 38 people who had been in close contact with him. (Reuters/Tyrone Siu)

Last Friday, China confirmed its first case of Middle East Respiratory Syndrome (MERS) in Guangdong province. The now-confirmed South Korean MERS patient, who ignored travel warnings and lied about his conditions when flying to China, had been in close contact with seventy-seven people in the province. As of June 1, sixty-four have been quarantined while the thirteen others remain to be found. Read more »

Podcast: China’s Environmental Health Crisis – Challenges and Politics

by Yanzhong Huang
Women wear face masks on the Bund in front of the Oriental Pearl TV Tower during a hazy day in downtown Shanghai January 26, 2015. (Aly Song/Courtesy Reuters) Women wear face masks on the Bund in front of the Oriental Pearl TV Tower during a hazy day in downtown Shanghai January 26, 2015. (Aly Song/Courtesy Reuters)

After more than three decades of rapid industrialization and modernization, China is on the cusp of potentially becoming the world’s largest economy. Yet China’s economic miracle has imposed tremendous costs on the environment and public health. Topping this list is extensive air pollution, water pollution, and soil contamination—outdoor air pollution, for example, has been linked to 1.2 million premature deaths in China. The result, as shown in the recent viral documentary “Under the Dome,” has been an environmental health crisis that has profound economic, social, and political ramifications. The ascending popularity of the documentary, followed by its quick disappearance from all major websites in China, beget a series of questions on China’s environmental health crisis: What is the nature and magnitude of the crisis? What are its causes and consequences?  What is the response of the Chinese government to the crisis and is this response sufficient to the challenges at hand? Read more »

The Anti-Corruption Drive and Risk of Policy Paralysis in China

by Yanzhong Huang
China's Politburo Standing Committee members (2nd row from bottom, L to R) Wang Qishan, Zhang Dejiang, President Xi Jinping, Premier Li Keqiang, Liu Yunshan and Yu Zhengsheng (bottom row, 2nd R) sing Chinese national anthem at the closing session of the Chinese People's Political Consultative Conference (CPPCC) at the Great Hall of the People in Beijing, March 13, 2015. (Kim Kyung-Hoon/Courtesy: Reuters) China's Politburo Standing Committee members (2nd row from bottom, L to R) Wang Qishan, Zhang Dejiang, President Xi Jinping, Premier Li Keqiang, Liu Yunshan and Yu Zhengsheng (bottom row, 2nd R) sing Chinese national anthem at the closing session of the Chinese People's Political Consultative Conference (CPPCC) at the Great Hall of the People in Beijing, March 13, 2015. (Kim Kyung-Hoon/Courtesy: Reuters)

Like it or not, President Xi Jinping’s anti-corruption campaign is extremely popular among Chinese people. According to an online survey, “combating corruption” trails “income distribution” as the top two concerns of the Chinese public. There are already reports suggesting that the campaign has helped reduce the transaction cost for ordinary people to get things done in China. Read more »

Artemisinin’s Rocky Road to Globalization: Part III

by Yanzhong Huang
A Ministry of Public Health official holds blood test slides taken from children, who live in the Thai-Myanmar border, at a malaria clinic in the Sai Yoke district, Kanchanaburi Province October 26, 2012. Globally, 3.3 billion people are at risk of malaria infection. While Africa has the highest malaria burden, most the 46,000 deaths outside Africa occurred in Asia Pacific. There are also concerns over a growing parasite resistance. Studies and research show artemisinin-based therapies - currently the most effective treatment against malaria - are taking longer to cure some of the patients. (Sukree Sukplang/Courtesy: Reuters) A Ministry of Public Health official holds blood test slides taken from children, who live in the Thai-Myanmar border, at a malaria clinic in the Sai Yoke district, Kanchanaburi Province October 26, 2012. Globally, 3.3 billion people are at risk of malaria infection. While Africa has the highest malaria burden, most the 46,000 deaths outside Africa occurred in Asia Pacific. There are also concerns over a growing parasite resistance. Studies and research show artemisinin-based therapies - currently the most effective treatment against malaria - are taking longer to cure some of the patients. (Sukree Sukplang/Courtesy: Reuters)

In the previous blog post, I discussed how China’s efforts to promote its artemisinin-based drugs in the global market have ended up placing their pharmaceutical firms at the lower end of the supply chain. Not all Chinese pharmaceutical companies were content with this arrangement. In 1994, Beijing Holley-Cotec became the first Chinese manufacturer to export dihydroartemisinin (“Cotecxin”), one of the artemisinin derivatives that the company developed with an original Chinese brand. Read more »

Artemisinin’s Rocky Road to Globalization: Part II

by Yanzhong Huang
A health worker checks a blood sample for malaria in the only hospital in Pailin in western Cambodia January 28, 2010. Bordering with Thailand, this former Khmer Rouge stronghold and dusty gem mining town is now better known for a malarial parasite that is worrying health experts in the region. Studies and research show artemisinin-based therapies - currently the most effective treatment against malaria - are taking longer to cure some of the patients. (Damir Sagolj/ Courtesy: Reuters) A health worker checks a blood sample for malaria in the only hospital in Pailin in western Cambodia January 28, 2010. Bordering with Thailand, this former Khmer Rouge stronghold and dusty gem mining town is now better known for a malarial parasite that is worrying health experts in the region. Studies and research show artemisinin-based therapies - currently the most effective treatment against malaria - are taking longer to cure some of the patients. (Damir Sagolj/ Courtesy: Reuters)

In my previous blog post, I described how artemisinin-based drugs were discovered in China in the 1970s and 1980s. Given their potency for the treatment of malaria, one would expect that Chinese made artemisinin-based drugs quickly became the first choice medicine in the global fight against malaria. Much to the chagrin of Chinese scientists and pharmaceutical companies, the World Health Organization (WHO) did not list a single one of China’s antimalarial drugs on its procurement list until 2007.

Read more »

Artemisinin’s Rocky Road to Globalization: Part I

by Yanzhong Huang
A Thai Public Heath Ministry official places a thermometer into a child's mouth at a malaria clinic in Sai Yoke district, Kanchanaburi Province October 26,2012. The child, who lives on the Thai-Myanmar border, came to the clinic to get tested for malaria. Globally, 3.3 billion people are at risk of malaria infection. While Africa has the highest malaria burden, most the 46,000 deaths outside Africa occurred in Asia Pacific. There are also concerns over a growing parasite resistance. Studies and research show artemisinin-based therapies - currently the most effective treatment against malaria - are taking longer to cure some of the patients. REUTERS/Sukree Sukplang (THAILAND - Tags: POLITICS HEALTH) A Thai Public Heath Ministry official places a thermometer into a child's mouth at a malaria clinic in Sai Yoke district, Kanchanaburi Province, on October 26, 2012 (Sukree Sukplang/Courtesy of Reuters).

Artemisinin, or Qinghaosu, is isolated from Artemisia annua L., a plant native to China but now naturalized in many other countries. Today, the artemisinin group of drugs is considered the most efficacious and fast-acting antimalarial known to the humankind. In 2011, Dr. Tu Youyou, a Chinese medical scientist, won the Lasker Award in Clinical Medicine—one of the most respected science prizes in the world—for discovering the antimalarial treatment that has saved millions of lives worldwide, especially in the developing countries. Read more »

China, Japan, and the Twenty-One Demands

by Yanzhong Huang
Chinese (L) and Japanese Buddhist monks pray next to candles during a memorial ceremony on the 77th anniversary of the Nanjing Massacre, in Nanjing, Jiangsu province, December 13, 2014. China and Japan should set aside hatred and not allow the minority who led Japan to war to affect relations now, Chinese President Xi Jinping said on Saturday, as the country marked its first national memorial day for the Nanjing Massacre. Picture taken December 13, 2014. (Stringer/Courtesy Reuters) Chinese (L) and Japanese Buddhist monks pray next to candles during a memorial ceremony on the 77th anniversary of the Nanjing Massacre, in Nanjing, Jiangsu province, December 13, 2014. China and Japan should set aside hatred and not allow the minority who led Japan to war to affect relations now, Chinese President Xi Jinping said on Saturday, as the country marked its first national memorial day for the Nanjing Massacre. Picture taken December 13, 2014. (Stringer/Courtesy Reuters)

Compared with the high-profile national Memorial Day for the Nanjing Massacre last month, the date January 18 passed uneventfully. Chinese media appeared to have forgotten that one hundred years ago, on exactly that day, Japan presented Chinese President Yuan Shikai (Yuan Shih-Kai) with requests that would have turned China into a de facto Japanese protectorate. Read more »

2014: The Top Ten Stories in China’s Health Sector

by Yanzhong Huang
Beijing, China. A resident walks along street on a polluted day. (China Daily/Courtesy: Reuters) Beijing, China. A resident walks along street on a polluted day. (China Daily/Courtesy: Reuters)

1. China formally enters post-Global Fund era

By the end of 2013, the Global Fund to Fight AIDS, Tuberculosis, and Malaria officially closed its portfolio in China. Having approved $1.81 billion to support China’s fight against the three diseases, the Global Fund was the largest international health cooperation program in China. One decade of the Global Fund’s presence in China has left behind a mixed legacy. With the departure of the Global Fund, sustaining the existing level of achievement becomes a daunting challenge. Already, the government has eliminated one trademark of the Global Fund: the Country Coordinating Mechanism (CCM). Read more »

Where to Look for the Next Jack Ma?

by Yanzhong Huang
Alibaba Group Executive Chairman Jack Ma delivers a keynote speech during the Cross-Strait CEO Summit in Taipei, December 15, 2014. (Pichi Chuang/ Courtesy: Reuters). Alibaba Group Executive Chairman Jack Ma delivers a keynote speech during the Cross-Strait CEO Summit in Taipei, December 15, 2014. (Pichi Chuang/ Courtesy: Reuters).

Where to look for the next Jack Ma? This is a trillion dollar question. According to a document released by the State Council (China’s cabinet) last October, by 2020 the size of China’s health service industry—which covers medical care, pharmaceutical products, healthcare products, medical devices, and health management—would reach 8 trillion RMB (or $1.3 trillion), up from less than 1.7 trillion RMB in 2012. This would mean an annual growth rate of 21 percent between 2012 and 2020. Read more »